These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18706947)

  • 1. Bioresponsive drug delivery for regenerative medicine.
    Park K
    J Control Release; 2008 Sep; 130(3):201. PubMed ID: 18706947
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
    Hardwicke J; Ferguson EL; Moseley R; Stephens P; Thomas DW; Duncan R
    J Control Release; 2008 Sep; 130(3):275-83. PubMed ID: 18700156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds.
    Hardwicke J; Moseley R; Stephens P; Harding K; Duncan R; Thomas DW
    Mol Pharm; 2010 Jun; 7(3):699-707. PubMed ID: 20166755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidermal growth factor (EGF) and wound healing].
    Laato M; Niinikoski J
    Duodecim; 1990; 106(11):860-2. PubMed ID: 1670323
    [No Abstract]   [Full Text] [Related]  

  • 5. A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets.
    Kitajima T; Sakuragi M; Hasuda H; Ozu T; Ito Y
    Acta Biomater; 2009 Sep; 5(7):2623-32. PubMed ID: 19376761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation development of epidermal growth factor.
    Lee J
    Pharmazie; 2002 Dec; 57(12):787-90. PubMed ID: 12561235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the potential of polymer therapeutics in corneal re-epithelialisation.
    Hardwicke J; Song B; Moseley R; Thomas DW
    Br J Ophthalmol; 2010 Dec; 94(12):1566-70. PubMed ID: 20829315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes.
    Lan CC; Liu IH; Fang AH; Wen CH; Wu CS
    Br J Dermatol; 2008 Nov; 159(5):1103-15. PubMed ID: 18717678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of fibrin mat and Tegaderm wound dressing for the delivery of keratinocytes--implications of their use to treat burns.
    Chua AW; Ma DR; Song IC; Phan TT; Lee ST; Song C
    Burns; 2008 Mar; 34(2):175-80. PubMed ID: 18029101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant EGF protein delivered by a biodegradable cell transplantation system.
    Voigt M; Andree C; Kalt T; Dörmann S; Schaefer DJ; Walgenbach KJ; Stark GB
    Tissue Eng; 2002 Apr; 8(2):263-72. PubMed ID: 12031115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in novel drug delivery systems for wound healing.
    Pachuau L
    Expert Opin Drug Deliv; 2015; 12(12):1895-909. PubMed ID: 26289672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanocomposites for the delivery of bioactive molecules in tissue repair: vital structural features, application mechanisms, updated progress and future perspectives.
    Du Z; Cao G; Li K; Zhang R; Li X
    J Mater Chem B; 2020 Dec; 8(45):10271-10289. PubMed ID: 33084730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects on tumour cells and promotion of keratinocyte wound healing by different lichen compounds.
    Burlando B; Ranzato E; Volante A; Appendino G; Pollastro F; Verotta L
    Planta Med; 2009 May; 75(6):607-13. PubMed ID: 19199230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds.
    Hong JP; Kim YW; Lee SK; Kim SH; Min KH
    Ann Plast Surg; 2008 Oct; 61(4):457-62. PubMed ID: 18812721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery technologies and stem cells for tissue repair and regeneration.
    Orive G; Cobos R; Gorriti J; Pedraz JL; Meregalli M; Torrente Y
    Curr Pharm Biotechnol; 2015; 16(7):646-54. PubMed ID: 25934974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds.
    Hrynyk M; Martins-Green M; Barron AE; Neufeld RJ
    Int J Pharm; 2010 Oct; 398(1-2):146-54. PubMed ID: 20691251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor-functionalized polymeric multilayer films: interplay between spatial location and bioavailability of EGF.
    Gorouhi F; Shah NM; Krishna Raghunathan V; Mohabbati Y; Abbott NL; Isseroff RR; Murphy CJ
    J Invest Dermatol; 2014 Jun; 134(6):1757-1760. PubMed ID: 24390131
    [No Abstract]   [Full Text] [Related]  

  • 18. Wound-healing activity of Astragali Radix in rats.
    Han DO; Lee HJ; Hahm DH
    Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):95-100. PubMed ID: 19455264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of topical analgesics on ex vivo skin growth and human keratinocyte and fibroblast behavior.
    Harris KL; Bainbridge NJ; Jordan NR; Sharpe JR
    Wound Repair Regen; 2009; 17(3):340-6. PubMed ID: 19660041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro.
    D'Alessio S; Gerasi L; Blasi F
    J Cell Sci; 2008 Dec; 121(Pt 23):3922-32. PubMed ID: 19001498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.